|
Volumn 143, Issue 3, 2000, Pages 353-361
|
Occurrence and effects of octreotide antibodies during nasal, subcutaneous and slow release intramuscular treatment
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOPEPTIN;
GROWTH HORMONE;
HORMONE ANTIBODY;
IODINE 125;
MACROGOL;
OCTREOTIDE;
SOMATOMEDIN C;
SOMATOSTATIN;
ACROMEGALY;
ANTIBODY PRODUCTION;
ARTICLE;
CARCINOID SYNDROME;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSS REACTION;
DENMARK;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG EXPOSURE;
GROWTH HORMONE BLOOD LEVEL;
HUMAN;
ITALY;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
RHINITIS;
ROMANIA;
SKIN MANIFESTATION;
SNEEZING;
TREATMENT OUTCOME;
UNITED KINGDOM;
|
EID: 0033804121
PISSN: 08044643
EISSN: None
Source Type: Journal
DOI: 10.1530/eje.0.1430353 Document Type: Article |
Times cited : (12)
|
References (15)
|